Cell Signaling Technology

AP-2 beta Antibody

#2509 · $317

100
Citing papers
20.8k
Combined citations
Supplier page Find this product

Research areas

Cancer Immunotherapy and Biomarkers13Cancer-related molecular mechanisms research8Protein Kinase Regulation and GTPase Signaling6PI3K/AKT/mTOR signaling in cancer6Genetic factors in colorectal cancer6RNA modifications and cancer6Colorectal Cancer Treatments and Studies6Immune cells in cancer5

Papers citing this product

1
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Genome Medicine·2019·1.7k cit.·DOI
2
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Journal of Clinical Investigation·2010·1.2k cit.·DOI
3
A systems study reveals concurrent activation of AMPK and mTOR by amino acids
Nature Communications·2016·446 cit.·DOI
4
Histone deacetylase degradation andMEF2 activation promote the formation of slow-twitch myofibers
Journal of Clinical Investigation·2007·423 cit.·DOI
5
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
Nature·2018·415 cit.·DOI
6
Implications of the tumor immune microenvironment for staging and therapeutics
Modern Pathology·2017·364 cit.·DOI
7
Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex
Journal of Clinical Investigation·2004·362 cit.·DOI
8
Distinct Compartmentalization of the Chemokines CXCL1 and CXCL2 and the Atypical Receptor ACKR1 Determine Discrete Stages of Neutrophil Diapedesis
Immunity·2018·361 cit.·DOI
9
Mouse Retinal Cell Atlas: Molecular Identification of over Sixty Amacrine Cell Types
Journal of Neuroscience·2020·357 cit.·DOI
10
Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation
Nature Communications·2017·321 cit.·DOI